Your browser doesn't support javascript.
loading
Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.
Briggs, Emily; Kamal, Mohamed A; Kosloski, Matthew P; Linsmeier, Ian; Jusko, Natalie; Dolphin, Nancy; Chittenden, Jason; Simpson, Eric L; Paller, Amy S; Siegfried, Elaine C; Shumel, Brad; Levit, Noah A; Bansal, Ashish; Davis, John D; Chapel, Sunny; Smith, David E; Huniti, Nidal.
Affiliation
  • Briggs E; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
  • Kamal MA; A2-Ai, Ann Arbor, MI, USA.
  • Kosloski MP; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA. Mohamed.kamal@regeneron.com.
  • Linsmeier I; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Jusko N; Arcus Biosciences, Hayward, CA, USA.
  • Dolphin N; Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.
  • Chittenden J; Amador Bioscience, Ann Arbor, MI, USA.
  • Simpson EL; Amador Bioscience, Ann Arbor, MI, USA.
  • Paller AS; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Siegfried EC; Oregon Health and Science University, Portland, OR, USA.
  • Shumel B; Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
  • Levit NA; Ann and Robert H. Lurie Children's Hospital, Chicago, IL, USA.
  • Bansal A; Saint Louis University, St. Louis, MO, USA.
  • Davis JD; Cardinal Glennon Children's Hospital, St. Louis, MO, USA.
  • Chapel S; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
  • Smith DE; Dermatology Physicians of Connecticut, Fairfield, CT, USA.
  • Huniti N; Regeneron Pharmaceuticals Inc, Tarrytown, NY, USA.
Pharm Res ; 40(11): 2653-2666, 2023 Nov.
Article in En | MEDLINE | ID: mdl-38082089

Full text: 1 Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Adolescent / Adult / Child / Humans Language: En Year: 2023 Type: Article

Full text: 1 Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Adolescent / Adult / Child / Humans Language: En Year: 2023 Type: Article